Halyard Health (NYSE:HYH) said last week it expects the restructuring of its information technology systems could cost between $40 and $50 million. The Alpharetta, Ga.-based company said it sold its previous IT systems alongside its surgical and infection prevention business to Owens & Minor (NYSE:OMI) in a deal worth $710 million, which it announced last November. The purchase […]
Avanos Medical (formerly Halyard Health)
Halyard Health levies suit at ex-parent co Kimberly Clark
Halyard Health (NYSE:HYH) is suing its former parent company Kimberly-Clark seeking to clear Halyard’s responsibility to pay for $354 million in damages in a fraud case decided last April. In the case, plaintiffs alleged that Kimberly-Clark and Halyard Health engaged in common law fraud and violations of California’s Unfair Competition Law in connection with their marketing […]
Halyard Health posts Street-beating Q4, full-year results
Shares in Halyard Health (NYSE:HYH) fell slightly today after the medical device maker met expectations on Wall Street with its fourth quarter and full-year finances. The company is in the middle of a $710 million divestiture of its surgical and infectious disease prevention business to Owens & Minor (NYSE:OMI), so it reported financial results for both on-going […]
How medtech could stop the drug overdose crisis in the U.S.
The opioid epidemic is one of the deadliest problems facing the U.S. today. Through the development of new pain management devices, medtech could be a leader in solving the crisis. The prescription opioid overdose crisis in America didn’t start until the late 1990s, when pharmaceutical companies touted prescription painkillers that weren’t supposed to be addictive. […]
7 medical devices combating the opioid crisis
Opioid-related deaths have become an epidemic in the U.S., garnering attention from the White House, the FDA and many other governmental bodies. From 2000 to 2014, nearly half a million Americans died from drug overdoses. In 2015, more than 50,000 people died from drug overdoses, and 33,000 were opioid-related. Prescription overdoses continue to cause more […]
Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017
Vascular Dynamics said early this month it tapped former NuVasive Inc. (NSDQ:NUVA) exec and Ellipse Technologies CEO Ed Roschak as its new president and chief executive. Prior to joining Mountain View, Calif.-based Vascular Dynamics, Roschak served as prez and CEO of Ellipse Technologies, which he saw through a $410 million acquisition by NuVasive. He then took up […]
Owens & Minor to buy Halyard Health’s infection prevention biz for $710m
Owens & Minor (NYSE:OMI) agreed to pay $710 million to acquire Halyard Health‘s (NYSE:HYH) surgical and infection prevention business. The deal, expected to close during the first quarter next year, adds $1 billion in revenues and $80 million in earnings before interest, taxes, depreciation & amortization to Owen’s & Minor’s books annually. “Halyard’s S&IP business […]
Halyard Health rises on Q2 EPS beat
Shares in Halyard Health (NYSE:HYH) rose today after the medical device maker beat expectations on Wall Street with its 2nd quarter earnings. The Alpharetta, Ga.-based company posted profits of $17.1 million, or 36¢ per share, on sales of $399.2 million for the 3 months ended June 30, for massive bottom-line growth of 163.1% while sales shrank […]
Halyard Health taps former Acelity head Woody for CEO | Personnel Moves July 5, 2017
Halyard Health (NYSE:HYH) said late last month it tapped former Acelity prez & CEO Joseph Woody as its new chief executive officer, replacing a retiring Robert Abernathy. Woody will also assume a seat on the board of directors, with former CEO Abernathy continuing on as board chair, the Alpharetta, Ga.-based company said. “On behalf of the […]
Halyard Health mulls sale of hospital supplies biz
Halyard Health (NYSE:HYH) is mulling a shift in focus to medical devices by selling off its surgical and infection prevention business, which could fetch more than $600 million, people familiar with the matter told Reuters yesterday. The move would ditch its line of underperforming, low-margin commodities in favor of its line of post-operative pain management devices. […]
Halyard Health shares dip despite posting Street-Beating Q1
Halyard Health (NYSE:HYH) has seen shares drop today despite the medical device maker surpassing expectations on Wall Street with its 1st quarter earnings results. The Alpharetta, Ga.-based company posted profits of $12.8 million, or 27¢ per share, on sales of $395.6 million for the 3 months ended March 31, for negative bottom-line growth of 9.9% on […]